Skin lesions in diabetes mellitus: Prevalence and clinical correlations

Diabetes Research and Clinical Practice

Volumn 39, Issue 2, 1998, Pages 101-106

  Romano, G ^a   Moretti, G ^b   Di Benedetto, A ^a   Giofre C ^b   Di Cesare, E ^a   Russo, G ^a   Califano, L ^b   Cucinotta, D ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Diabetes mellitus; IDDM; Metabolic control; NIDDM; Skin lesions

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DISEASE CONTROL; ECZEMA; ELECTROCARDIOGRAM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PREVALENCE; PSORIASIS; QUALITY OF LIFE; SKIN DEFECT; SKIN INFECTION; VITILIGO;

ADOLESCENT; ADULT; AGED; CANDIDIASIS; DERMATOMYCOSES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; HYPOGLYCEMIC AGENTS; INSULIN; ITALY; MALE; MIDDLE AGED; PREVALENCE; SKIN; SKIN DISEASES;

EID: 0031971544     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(97)00119-8     Document Type: Article

References (17)

1. Braverman I. Cutaneous manifestations of diabetes mellitus. Med. Clin. North Am. 55:1971;1019-1029.
2. J.E. Jelinek, Skin disorders associated with diabetes mellitus, in: H. Rifkin, D. Porte (Eds.), Ellenberg and Rifkin's Diabetes Mellitus, Theory and Practice, Elsevier, New York, NY, 1990, pp. 838-849.
3. S.E. Hall, R.G. Sibbald, The skin in diabetes mellitus, in: J.C. Pickup, G. Williams (Eds.), Chronic Complications of Diabetes, Blackwell, Oxford, 1994, pp. 250-259.
4. Perez M.I., Kohn S.R. Cutaneous manifestations of diabetes mellitus. J. Am. Acad. Dermatol. 30:1994;519-531.
5. Sibbald R.G., Schachter R.K. The skin and diabetes mellitus. Int. J. Dermatol. 23:1984;567-584.
6. Huntley A.C. The cutaneous manifestations of diabetes mellitus. J. Am. Acad. Dermatol. 7:1982;427-455.
7. WHO Study Group, Diabetes Mellitus, Technical Report Series 727, World Health Organization, Geneva, 1985.
8. Fedele D., Comi G., Coscelli C., Cucinotta D., Feldman E.L., Ghirlanda G., Greene D.A., Negrin P., Santeusanio F. A multicentre study on the prevalence of diabetic neuropathy in Italy. Diabetes Care. 20:1997;836-843.
9. Blackburn H., Keys A., Simonsen E., Rautaharju P., Punsar S. The electrocardiogram in population studies: a classification system. Circulation. 21:1960;1160-1175.
10. Wilson R.M., Reeves W.G. Neutrophil phagocytosis and killing in insulin-dependent diabetes. Clin. Exp. Immunol. 63:1986;478-484.
11. Tebbs S.E., Gonzales A.M., Wilson R.M. The role of aldose reductase inhibition in diabetic neutrophil phagocytosis and killing. Clin. Exp. Immunol. 84:1991;482-487.
12. Hill L.V., Tan M.H., Pereira L.H., Embil J.A. Association of oral candidosis with diabetes control. J. Clin. Pathol. 42:1989;502-507.
13. R.M. Wilson, Infections and diabetes mellitus, in: J.C. Pickup, G. Williams (Eds.), Chronic Complications of Diabetes, Blackwell, Oxford, 1994, pp. 282-288.
14. Feingold K.R., Elias P.M. Endocrine-skin interactions. J. Am. Acad. Dermatol. 17:1987;921-940.
15. Goodfield M.J.D., Millard L.G. The skin in diabetes mellitus. Diabetologia. 31:1988;567-575.
16. Vijuyusingam S.M., Thai A.C., Chan H.L. Non-infective skin associations of diabetes mellitus. Ann. Acad. Med. 17:1988;526-535.
17. Lithner F., Bergenheim T., Borssen B. Extensor digitorum brevis in diabetic neuropathy: a controlled evaluation in diabetic patients aged 15-50 years. J. Int. Med. 230:1991;449-453.